Search

Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-year-olds.

Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot

Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.

A man receives a COVID-19 vaccine at the vaccination super station at Grossmont Center in La Mesa, Calif. Feb. 2, 2021.

Infectious disease specialist: 'It's crucial first responders get vaccinated'

San Diego’s vaccination mandate for city employees is approaching.

Arriving South Korean tourists receive flower garlands at Phu Quoc international airport on November 20, 2021, as the island welcomes its first international tourists to arrive after a Covid-19 coronavirus vaccine passport scheme kicked off this month in Vietnam.

The U.N. predicts that 2021 global tourism losses will barely improve over last year

The recent emergence of the highly transmissible omicron variant presents another potential hurdle as the tourism industry prepares for the upcoming winter holiday season.

Patients queue to get vaccinated against COVID-19, in Aristotelous Square, in the center of the Greek city of Thessaloniki on November 26, 2021.

Greece will mandate the COVID-19 vaccine for anyone over 60, or make them pay fines

Anyone who refuses to get vaccinated will face monthly fines of 100 euros, or roughly $114. The monthly fine is substantial for retirees — the average pension is 730 euros a month.

A registered nurse stirs a nasal swab in testing solution after administering a COVID-19 test in Los Angeles, Calif. Increased testing could help in efforts to detect and track new variants like omicron.

U.S. races to detect and track omicron, hampered by an unwieldy surveillance system

What's the U.S. doing to watch out for the omicron variant? Here's the work underway and the challenges that experts say may slow down the country's efforts.

This undated file image provided by Merck & Co. shows their new antiviral medication molnupiravir. An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus

FDA panel narrowly backs COVID-19 pill from Merck

It sets the stage for an expected authorization of the first pill that Americans could take at home for the coronavirus.

The omicron variant might have originated in someone with a suppressed immune system

How did the coronavirus end up mutating into the omicron variant? One hypothesis is that it spent months replicating in the body of someone whose immune system was suppressed by uncontrolled HIV.

What we know about the omicron variant

The omicron variant of the not been found in the United States yet. Here's what's we known about it, how dangerous it's likely to be, and whether vaccines or new drugs will be effective against it.

Traders work on the floor of the New York Stock Exchange at the start of trading on Monday following Friday's steep decline in global stocks over fears of the new omicron coronavirus variant discovered in South Africa.

Stocks dive over the potential economic fallout from the omicron variant

Stocks fell on Tuesday as investors weighed the potential economic fallout from the new coronavirus variant. Federal Reserve Chair Jerome Powell said the central bank could end its bond-buying early.

Dutch health authorities say they've identified early cases of the new omicron variant of the coronavirus — including one from a sample taken the week before South Africa raised the alarm about the mutated variant. Other cases were found through tests at Schiphol airport in Amsterdam.

The omicron variant was in Europe a week before South Africa reported it

The rapidly spreading variant was identified in retests of samples that were taken on Nov. 19 and 23 in the Netherlands, according to a Dutch health agency.

Search results for